Explore ViiV Healthcare
Our medicines
| Product brand name (generic name) |
Class |
|---|---|
| 3TC (lamivudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Cabenuva (cabotegravir/rilpivirine) | lntegrase inhibitor (INI) and Non-nucleoside reverse transcriptase inhibitor (NNRTI) |
| Celsentri (maraviroc) | CCR5 antagonist |
| Combivir (lamivudine/zidovudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Dovato (dolutegravir/lamivudine) | lntegrase inhibitor (INI) and Non-nucleoside reverse transcriptase inhibitor (NNRTI) |
| Juluca (dolutegravir/rilpivirine) | Integrase inhibitor (INI) and Non-nucleoside reverse transcriptase inhibitor (NNRTI) |
| Kivexa (abacavir/lamivudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Retrovir (zidovudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Rukobia (fostemsavir) | Attachment inhibitor (AI) |
| Telzir (fosamprenavir) | Protease inhibitor (PI) |
| Tivicay (dolutegravir) | Integrase inhibitor (INI) |
| Triumeq (dolutegravir/abacavir/lamivudine) | Integrase inhibitor (INI) and Nucleoside reverse transcriptase inhibitor (NRTI) |
| Trizivir (abacavir/lamivudine/zidovudine) | Nucleoside reverse transcriptase inhibitor (NRTI) |
| Vocabria (cabotegravir) | Integrase Inhibitor (INI) |
| Ziagen (abacavir) | Nucleoside reverse transcriptase inhibitor (NRTI) |
Date of preparation: August 2021. PM-AU-HVX-WCNT-210005